SYNTHETIC COMMUNICATIONS®
7
1
acquired in KBr on a Pye Unicam Sp-3–300 infrared spectrophotometer. The H NMR
spectra were measured on a Bruker Avance 400 spectrometer at 400.0 MHz. The chemical
shifts were measured relative to DMSO-d6 proton signal. The melting points were
determined on an Electro thermal IA 9100 apparatus and are uncorrected.
N-((3-(Cinnamoylcarbamothioyl)-4-hydroxyphenyl)carbamothioyl)cinnamamide (3)
A mixture of cinnamoyl isothiocyanate (0.02 mol, 3.78 g) and 4-aminophenol 2 (0.02 mol,
2.18 g) in acetone (30 mL) was stirred at room temperature for 2 h, then poured onto cold
water, the solid formed was heated with sodium bicarbonate, filtered and recrystallized
from ethanol to give 3. Yield: 7.89 g (81%); brown crystals; m.p. > 340 °C. IR (KBr):
−1
3423 (NH, OH) 1672, 1623 (C O), 1258 (C S) cm . 1H NMR (DMSO-d6, ppm) δ
6.67–7.78 (m, 17H, olefinic-H and Ar-H), 9.60 (s, 1H, OH), 11.50 (s, 1H, 2NH), 12.49
(s, 1H, NH). 13C NMR (100 MHz, DMSO-d6, ppm): 89.7, 97.3, 114.1, 115.9, 120.5,
120.8, 120.9, 124.8, 126.6, 127.4, 128.2, 128.9, 129.1, 129.96, 131.6, 134.0, 143.8, 144.8,
155.6, 166.1, 175.5, 178.7. Anal: C26H21N3O3S2 (487.59); Calcd: C, 64.04; H, 4.34;
N, 8.62. Found: C, 64.11; H, 4.38; N, 8.57.
=
=
Conclusion
In summary, we report an efficient and facile synthetic approaches for some pyrimidine
thiones, triazines, triazoles, and thiadiazole. Cinnamoyl isothiocyanate was treated with a
variety of N-nucleophilic reagents affording thiourea or thiosemicarbazide derivatives,
the later intermediates were underwent intramolecular cyclization to give the target
compounds.
References
[1] Tozkoparan, B.; Ertan, M.; Kelicen, P.; Demirdamar, R. Synthesis and Anti-Inflammatory
Activities of Some Thiazolo[3,2-a]Pyrimidine Derivatives. Farmaco 1999, 54, 588–593. DOI:
[2] Jeanneau-Nicolle, E.; Benoit-Guyod, M.; Namil, A.; Leclerc, G. New Thiazolo[3,2-a]Pyrimidine
Derivatives, Synthesis and Structure-Activity Relationships. Eur. J. Med. Chem. 1992, 27,
115–120.
[3] Pan, B.; Huang, R.; Zheng, L.; Chen, C.; Han, S.; Qu, D.; Zhu, M.; Wei, P. Thiazolidione
Derivatives as Novel Antibiofilm Agents: Design, Synthesis, Biological Evaluation, and
Structure - Activity Relationships. Eur. J. Med. Chem. 2011, 46, 819–824.
[4] Mohamed, S. F.; Flefel, E. M.; Amr, A. E. G. E.; El-Shafy, D. N. Anti-HSV-1 Activity and
Mechanism of Action of Some New Synthesized Substituted Pyrimidine, Thiopyrimidine
and Thiazolopyrimidine Derivatives. Eur. J. Med. Chem. 2010, 45, 1494–1501.
[5] Maddila, S.; Damu, G.; Oseghe, E.; Abafe, O.; Rao, C. V.; Lavanya, P. Synthesis and Biological
Studies of Novel Biphenyl-3,5-dihydro-2H-Thiazolopyrimidines Derivatives. J. Korean Chem.
Soc. 2012, 56, 334–340.
[6] Flefel, E.; Salama, M.; El-Shahat, M.; El-Hashash, M.; El-Farargy, A. A Novel Synthesis of Some
New Pyrimidine and Thiazolopyrimidine Derivatives for Anticancer Evaluation. Phosphorus
Sulfur Silicon Relat. Elem. 2007, 182, 1739–1756.
[7] Danel, K.; Pedersen, E. B.; Nielsen, C. Synthesis and Anti-HIV-1 Activity of Novel 2,3-Dihydro-
7H-thiazolo[3,2-a]pyrimidin-7-ones. J. Med. Chem. 1998, 41, 191–198. DOI: 10.1002/chin.
[8] Alterman, M.; Samulsson, B. J.; Danielson, H. Design and Synthesis of New Potent
C2-Symmetric HIV-1 Protease Inhibitors. Use of l-Mannaric Acid as a Peptidomimetic
Scaffold. J. Med. Chem. 1998, 41, 3782–3792.